查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016153

避孕藥具市場報告：按產品、年齡層、分銷管道和地區分類（2026-2034 年）

Contraceptive Drugs Market Report by Product, Age Group, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年全球避孕藥市場規模達174億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到260億美元，2026年至2034年的複合年成長率為4.46%。

避孕藥是用來預防懷孕和控制生育率的藥物。它們由兩種抑制排卵的女性激素——雌激素和黃體激素——合成。這些荷爾蒙會使子宮頸黏液增稠，並改變子宮內膜的狀態，阻止精子進入子宮頸進行受精和著床。避孕藥有助於降低痤瘡、骨質疏鬆症、卵巢癌、輸卵管和子宮感染疾病以及月經症候群（PMS）的風險。因此，醫療保健專業人員會為育齡婦女開立避孕藥，以預防意外懷孕。目前，避孕藥主要有口服、注射和外用三種劑型。

避孕藥具市場趨勢：

全球避孕市場的主要促進因素之一是消費者對計劃生育意識的提高、人口成長以及意外懷孕率的上升。這促使醫療專業人員將工作重點從傳統方法轉向現代避孕方法，因為現代避孕方法具有許多優勢，包括更高的安全性和更好的臨床效果。此外，包括美國食品藥物管理局（FDA）在內的監管機構經常核准新藥，也推動了市場成長要素。明膠膠囊和非荷爾蒙陰道凝膠的出現，透過維持陰道pH值，創造不利於精子生存的環境，也促進了市場成長。此外，非政府組織（NGO）和衛生機構持續進行的研發活動以及為意識提升所做的努力，無疑也在推動市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球避孕藥市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 口服避孕藥
  • 注射式避孕藥
  • 局部避孕藥

第7章 市場區隔：依年齡層別分類

  • 15-24歲
  • 25-34歲
  • 35-44歲
  • 44歲或以上

第8章 市場區隔：依分銷通路分類

  • 零售藥房
  • 醫院藥房
  • 診所
  • 線上管道
  • 公共管道和非政府組織
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbvie, Inc.
    • Afaxys, Inc.
    • Agile Therapeutics, Inc.
    • Bayer AG
    • HLL Lifecare Limited
    • Organon group of companies
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Pharma Ltd.
    • Teva Pharmaceuticals USA, Inc.
Product Code: SR112026A6300

The global contraceptive drugs market size reached USD 17.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 26.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.46% during 2026-2034.

Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.

CONTRACEPTIVE DRUGS MARKET TRENDS:

One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women's health, and sexual wellness are positively augmenting the market growth.

KEY MARKET SEGMENTATION:

Breakup by Product:

  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives

Breakup by Age Group:

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Clinics
  • Online Channel
  • Public Channel and NGOs
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global contraceptive drugs market with detailed profiles of all major companies, including:

  • Abbvie, Inc.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Bayer AG
  • HLL Lifecare Limited
  • Organon group of companies
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Teva Pharmaceuticals USA, Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global contraceptive drugs market in 2025?

2. What is the expected growth rate of the global contraceptive drugs market during 2026-2034?

3. What are the key factors driving the global contraceptive drugs market?

4. What has been the impact of COVID-19 on the global contraceptive drugs market?

5. What is the breakup of the global contraceptive drugs market based on the product?

6. What is the breakup of the global contraceptive drugs market based on the age group?

7. What is the breakup of the global contraceptive drugs market based on the distribution channel?

8. What are the key regions in the global contraceptive drugs market?

9. Who are the key players/companies in the global contraceptive drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Contraceptive Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oral Contraceptive Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Contraceptives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Contraceptives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 15-24 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 25-34 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 35-44 years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Above 44 years
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Channel
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Public Channel and NGOs
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbvie, Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Afaxys, Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Agile Therapeutics, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Bayer AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 HLL Lifecare Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Organon group of companies
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Perrigo Company plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Piramal Pharma Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceuticals USA, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2025
  • Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Contraceptive Drugs (15-24 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Contraceptive Drugs (15-24 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Contraceptive Drugs (25-34 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Contraceptive Drugs (25-34 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Contraceptive Drugs (35-44 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Contraceptive Drugs (35-44 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2025
  • Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
  • Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
  • Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million USD), 2026-2034
  • Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Contraceptive Drugs Market: Competitive Structure
  • Table 7: Global: Contraceptive Drugs Market: Key Players